You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Atopic Dermatitis Forum

  • Authors: Peter A. Lio, MD; Robert Sidbury MD, MPH; April W. Armstrong, MD, MPH; Jenny E. Murase, MD
  • CME / ABIM MOC / CE Released: 11/28/2022
  • Valid for credit through: 11/28/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.50 ABIM MOC points

    Nurses - 1.50 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    IPCE - 1.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, allergists, clinical immunologists, primary care physicians (PCPs), pediatricians, nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with atopic dermatitis (AD).

The goal of this activity is for the learner to be better able to manage AD in different patient populations.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data on new/emerging topical AD medications
    • Data regarding targeted systemic agents for AD
    • Effect of different AD treatments on clinical symptoms
    • Evidence on safety and efficacy for targeted oral AD treatments
  • Have greater competence related to
    • Selecting AD treatments that consider patient-related factors such as age, severity, Fitzpatrick skin type, and comorbid conditions
  • Demonstrate greater confidence in their ability to
    • Team based roles in patient education


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

 

Disclosures for additional planners can be found here.


Faculty

  • Peter A. Lio, MD

    Clinical Assistant Professor of Dermatology and Pediatrics
    Northwestern University Feinberg School of Medicine
    Founding Director, Chicago Integrative Eczema Center
    Founding Partner, Medical Dermatology Associates of Chicago
    Chicago, Illinois

    Disclosures

    Peter A. Lio, MD, has the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Almirall; Altrus; Amyris; AOBiome; Arbonne; Aslan Pharmaceuticals; Bodewell; Boston Skin Science (KPAway); Burt’s Bees; Castle Biosciences; Concerto Biosciences; Dermavant; Exeltis; Galderma; IntraDerm; Janssen; Johnson & Johnson; Kaleido; Kimberly-Clark; Level Ex; Lilly; Lipidor; L’Oreal; Leo Pharma; Menlo; Micreos; My-Or Diagnostics; Pfizer; Pierre Fabre; Realm; Regeneron; Sanofi Genzyme; Theraplex; Unilever; Verrica; YobeeCare 
    Served as a speaker or a member of a speakers bureau for: AbbVie; Galderma; Incyte; Leo Pharma; Lilly; L’Oreal; Pfizer; Regeneron; Sanofi Genzyme 
    Received grants for clinical research from: AbbVie; AOBiome; Genzyme; Regeneron; Sanofi Genzyme 
    Contracted researcher for: AbbVie; AOBiome; Genzyme; Regeneron; Sanofi Genzyme 
    Royalties for: Theraplex 
    Patent beneficiary of: Theraplex 
    Owns stock options from: Altrus; Boston Skin Science (KPAway); Concerto Biosciences; LearnSkin; Micreos; YobeeCare 

  • Robert Sidbury MD, MPH

    Professor, Department of Pediatrics
    Chief, Division of Dermatology
    Seattle Children's Hospital
    University of Washington School of Medicine
    Seattle, Washington

    Disclosures

    Robert Sidbury, MD, MPH, has the following relevant financial relationships: 
    Served as an advisor or consultant for: Leo Pharma; Lilly 
    Served as a speaker or a member of a speakers bureau for: Beiersdorf 
    Received grants for clinical research from: Castle Biosciences; Galderma; Pfizer; Regeneron; UCB

  • April W. Armstrong, MD, MPH

    Professor of Dermatology
    Associate Dean of Clinical Research
    Keck School of Medicine
    University of Southern California
    Los Angeles, California

    Disclosures

    April W. Armstrong, MD, MPH, has the following relevant financial relationships: 
    Served as an advisor or consultant for: AbbVie; Almirall; Arcutis; Aslan Pharmaceuticals; Beiersdorf; Boehringer Ingelheim; Bristol Myers Squibb Company; Dermavant; Dermira; EPI Health; Janssen; Leo Pharma; Lilly; Modmed; Nimbus; Novartis; Ortho Dermatologics; Regeneron; Sanofi; Sun; UCB 
    Served as a speaker or a member of a speakers bureau for: AbbVie; Aslan Pharmaceuticals; Boehringer Ingelheim; Bristol Myers Squibb Company; Dermavant; Dermira; EPI Health; Incyte; Janssen; Lilly; Leo Pharma; Novartis; Ortho Dermatologics; Parexel; Pfizer; Sanofi; Sun; UCB 
    Received grants for clinical research from: AbbVie; Bristol Myers Squibb Company; Dermavant; Dermira; Galderma; Incyte; Janssen; Kyowa Kirin; Leo Pharma; Lilly; Novartis; Pfizer; Regeneron; UCB 

  • Jenny E. Murase, MD

    Director of Medical Consultative Dermatology
    Department of Dermatology
    Palo Alto Foundation Medical Group
    Associate Clinical Professor
    Department of Dermatology
    University of California, San Francisco
    San Francisco, California

    Disclosures

    Jenny E. Murase, MD, has the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Leo Pharma; Lilly; Sanofi Genzyme; UCB 
    Served as a speaker or a member of a speakers bureau for: Regeneron; UCB

Editor

  • Briana Betz, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Briana Betz, PhD, has no relevant financial relationships. 

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology. 

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Atopic Dermatitis Forum

Authors: Peter A. Lio, MD; Robert Sidbury MD, MPH; April W. Armstrong, MD, MPH; Jenny E. Murase, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 11/28/2022

Valid for credit through: 11/28/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

The Topical Atopic Dermatitis Toolbox

Are you using all the atopic dermatitis tools available?
Robert Sidbury, MD, MPH

New Data on Biologics for Atopic Dermatitis

Do you know the latest data in biologics?
April Armstrong, MD

The Evolving Landscape of Oral Systemic Atopic Dermatitis Therapies

Are you incorporating oral agents into your atopic dermatitis treatment strategies?
Peter A. Lio, MD

The Atopic Dermatitis Guideline Update

How are you talking to patients about managing comorbidities?
Robert Sidbury, MD, MPH

Challenging Cases in Atopic Dermatitis

How would you treat these pateints?
April Armstrong, MD; Peter A. Lio, MD; Jenny E. Murase, MD; Robert Sidbury, MD, MPH

Building the Case: The Relationship Between Allergic Contact Dermatitis and Atopic Dermatitis

When is it appropriate to patch test your atopic dermatitis patient?
Jenny E. Murase, MD

Building the Case: Early Atopic Dermatitis Treatment May Modify Disease Outcome

Is early aggressive treatment the right option?
Peter A. Lio, MD
 

Educational Impact Challenge

The goal of this activity is for the learner to be better able to manage AD in different patient populations.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print